| |
Cardiac Marker Diagnostic Testing Markets TriMark Publications TriMark Publications
Cardiac marker diagnostic testing measures the concentration of certain proteins, i.e., biomarkers, which indicate the presence or severity of cardiovascular disease (CVD). Among t
|
2011 |
3.400,00$ |
| |
Point of Care Diagnostic Testing Sector Trends TriMark Publications TriMark Publications
Point of care testing enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiti
|
2011 |
3.400,00$ |
| |
Cardiac Rhythm Management Devices World Markets TriMark Publications TriMark Publications
n the last five decades, electronic cardiac medicine has witnessed dramatic technological developments. The cardiac rhythm management products mainly marketed by a handful of globa
|
2011 |
3.400,00$ |
| |
Biomarker Technology Platforms for Cancer Diagnoses and Therapies TriMark Publications TriMark Publications
Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detecti
|
2011 |
3.400,00$ |
| |
Picture Archiving and Communications Systems (PACS) TriMark Publications TriMark Publications
During the past 35 years, ultrasound and nuclear medicine were introduced into clinical medicine, computed tomography (CT) revolutionized diagnostic procedures and magnetic resonan
|
2011 |
3.400,00$ |
| |
Mass Spectroscopy for Clinical Laboratory Analysis TriMark Publications TriMark Publications
Mass spectroscopy is a clinical laboratory analysis technique used in determining the basic composition and structure of a sample or molecule. The process involves bending a charge
|
2011 |
3.400,00$ |
| |
European Point of Care Diagnostic Testing Markets TriMark Publications TriMark Publications
Point of care testing (POCT) enables diagnostic tests to be performed rapidly while the patient remains at the point of care facility, such as a hospital, health clinic, doctor's o
|
2011 |
3.400,00$ |
| |
Point of Care Diagnostic Testing World Markets TriMark Publications TriMark Publications
Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather tha
|
2011 |
3.400,00$ |
| |
Molecular Diagnostics Markets TriMark Publications TriMark Publications
The technologies that constitute molecular diagnostics--like first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and mi
|
2011 |
3.400,00$ |
| |
Ultrasound Markets TriMark Publications TriMark Publications
Ultrasound represents a low-cost and efficacious imaging technology that continues to help radiologists and others collect significant clinical data about patients. Ultrasound is a
|
2011 |
3.400,00$ |
| |
Companion Diagnostics in Personalized Medicine and Cancer Therapy TriMark Publications TriMark Publications
A near-term market opportunity for cancer companion diagnostic tests exists in drug selection for cancer therapy. Co-development of molecular diagnostics and targeted therapeutics
|
2011 |
3.400,00$ |
| |
Molecular Diagnostics in Cancer Testing TriMark Publications TriMark Publications
Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umb
|
2011 |
3.400,00$ |
| |
Nuclear Cardiology Markets TriMark Publications TriMark Publications
Nuclear imaging for cardiac diseases helps in accurately diagnosing the disease and blood flow blockages. Gamma cameras and positron emission tomography (PET) scanners are the key
|
2011 |
3.400,00$ |
| |
Cancer Diagnostic Testing World Markets TriMark Publications TriMark Publications
Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten
|
2011 |
3.400,00$ |
| |
Molecular Diagnostics in Infectious Disease Testing TriMark Publications TriMark Publications
This TriMark Publications report describes the specific segment of the in vitro diagnostics market known as molecular diagnostics testing for infectious disease. In the current med
|
2011 |
3.400,00$ |
| |
Drugs of Abuse Testing Markets TriMark Publications TriMark Publications
This TriMark Publications report describes the specific segment of the in vitro diagnostics (IVD) market known as drugs of abuse testing. In the current medical diagnostics market,
|
2011 |
3.400,00$ |
| |
Mammography World Markets TriMark Publications TriMark Publications
Breast cancer is the most common type of cancer in women, affecting one in eight during their lives. Mammography is the most valuable method for detecting potentially cancerous ano
|
2011 |
3.400,00$ |
| |
Medical Imaging Markets TriMark Publications TriMark Publications
The purpose of this TriMark Publications report is to describe the specific market segment of the diagnostics market sector called medical imaging. Medical imaging can be categoriz
|
2011 |
3.400,00$ |
| |
Pharmaceuticals Bundle TriMark Publications TriMark Publications
Anti-Infective Drugs Markets
/ Cell Therapy Markets
/ Cell-Based Assays for Drug Discovery
/ Companion Biomarkers in Drug Development
/ Indian Pharmaceutical Industry
/ Medical Nanotechnology Markets
/ Pharmacogenomics for Clinical Use and in Drug Development
/ Therapeutic Monoclonal Antibod
|
2011 |
29.918,00$ |
| |
Molecular Diagnostics Bundle TriMark Publications TriMark Publications
Molecular Diagnostics in Cancer Testing
/ Molecular Diagnostics in Infectious Disease Testing
/ Molecular Diagnostics Markets
|
2011 |
8.670,00$ |
| |
Medical Devices Bundle TriMark Publications TriMark Publications
Cardiac Rhythm Management Devices World Markets
/ Disposable Medical Supplies Markets
/ Disposable Syringe Markets
/ Home Medical Testing Devices
/ Orthopedics Markets
/ Patient Monitoring Markets
/ Plastic Surgery Markets
/ Respiratory Therapeutics and Devices Markets
/ Sleep Disorders: In
|
2011 |
21.587,00$ |
| |
Cancer Bundle TriMark Publications TriMark Publications
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
/ Cancer Cell Therapy Markets
/ Cancer Diagnostic Testing World Markets
/ Cancer Therapeutics Markets
/ Companion Diagnostics in Personalized Medicine and Cancer Therapy
/ Cytology and HPV Testing World Markets
/ Molecular Diagn
|
2011 |
23.120,00$ |
| |
Medical Imaging Bundle TriMark Publications TriMark Publications
Mammography World Markets
/ Medical Imaging Markets
/ Nuclear Cardiology Markets
/ Picture Archiving and Communications Systems (PACS)
/ Positron Emission Tomography (PET) Markets
/ Ultrasound Markets
/ European Medical Imaging Markets
|
2011 |
16.657,00$ |
| |
Diagnostics Bundle TriMark Publications TriMark Publications
Cancer Diagnostic Testing World Markets.
/ Cardiac Marker Diagnostic Testing Markets.
/ Companion Diagnostics in Personalized Medicine and Cancer Therapy.
/ High-Growth Diagnostic Testing Markets.
/ Key Diagnostic Testing Markets.
/ Molecular Diagnostics in Cancer Testing.
/ Molecular Di
|
2011 |
32.639,00$ |
| |
Respiratory Therapeutics and Devices Markets TriMark Publications TriMark Publications
In the respiratory therapeutics and devices market, continuing new advancements in the ability to detect and manage respiratory diseases are being made. The respiratory disease spa
|
2011 |
3.400,00$ |
| |
India's In Vitro Diagnostic Testing Industry TriMark Publications TriMark Publications
The TriMark Publications "Sector Snapshot" is designed to provide a high-level overview of a particular market sector, including key players, sales data and emerging trends. This s
|
2011 |
500,00$ |
| |
European Medical Imaging Markets TriMark Publications TriMark Publications
The European market for medical imaging equipment continues to thrive despite the impact of a global economic recession. As such, the European medical imaging market represents a d
|
2011 |
3.400,00$ |
| |
Cancer Vaccines Markets TriMark Publications TriMark Publications
Cancer vaccines have the potential to become a significant force in future cancer treatments. In 2010, Dendreon's Provenge became the first cancer vaccine approved by the FDA, gene
|
2011 |
3.400,00$ |
| |
Orthopedics Markets TriMark Publications TriMark Publications
Orthopedics is a medical specialty that deals with the diagnosis and treatment of disorders and injuries to the skeletal system and the muscles, joints and ligaments associated wit
|
2011 |
3.400,00$ |
| |
Cytology and HPV Testing World Markets TriMark Publications TriMark Publications
Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread is not controlled, it can result in death. Cancer is caused by both e
|
2011 |
3.400,00$ |
| |
Positron Emission Tomography (PET) Markets TriMark Publications TriMark Publications
The medical imaging segments are poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital information technology s
|
2011 |
3.400,00$ |
| |
Genetics Bundle TriMark Publications TriMark Publications
Bioinformatics Markets
/ DNA Sequencing and PCR Markets
/ Gene Expression Reagents Markets
/ Genomics World Markets
/ Microarray Markets
/ Personalized Medicine
/ Pharmacogenomics for Clinical Use and in Drug Development
/ Regenerative Medicine Markets
/ RNA Interference Markets
/ Stem Cell
|
2010 |
25.327,00$ |
| |
Clinical Bundle TriMark Publications TriMark Publications
Clinical Chemistry Analyzers
/ Clinical Immunoanalyzer Markets
/ Clinical Laboratory Testing Volume 1: Reagents and Instruments
/ Clinical Laboratory Testing Volume 2: Business Strategies
|
2010 |
10.369,00$ |
| |
Automated Microbial Testing Markets TriMark Publications TriMark Publications
Microorganisms are ubiquitous and may be found in almost every environment on earth. As such, they are a diverse group with an assortment of genotypic and phenotypic features and v
|
2010 |
1.999,00$ |
| |
Clinical Chemistry Analyzers TriMark Publications TriMark Publications
Clinical chemistry analysis is one of the most important areas within clinical laboratory analysis. The term clinical chemistry usually refers to determining the concentration or a
|
2010 |
3.400,00$ |
| |
Microscopy Markets TriMark Publications TriMark Publications
This TriMark Publications report deals primarily with the analysis of market segments of microscopes used in clinical and research laboratories. Emphasis is on the U.S. markets; ho
|
2010 |
3.400,00$ |
| |
Clinical Immunoanalyzer Markets TriMark Publications TriMark Publications
Clinical immunoanalyzer analysis is one of the most important functions of clinical laboratory analysis. By all accounts, automated immunoassay testing is the most rapidly developi
|
2010 |
3.400,00$ |
| |
Anti-Infective Drugs Markets TriMark Publications TriMark Publications
Six infectious diseases--pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS--account for half of all premature deaths worldwide, killing mostly children and
|
2010 |
14.200,00$ |
| |
Plastic Surgery Markets TriMark Publications TriMark Publications
Modern advances in plastic surgery have allowed patients with severe physical deformities to live normal lives. Where at one time an individual suffering from an extreme physical a
|
2010 |
3.400,00$ |
| |
Clinical Laboratory Testing Volume 1: Reagents and Instruments TriMark Publications TriMark Publications
Clinical laboratory analysis for in vitro diagnostic (IVD) testing is one of the most important sectors of medical care. By all accounts, it is very mature, large market employing
|
2010 |
3.400,00$ |
| |
Clinical Laboratory Testing Volume 2: Business Strategies TriMark Publications TriMark Publications
Clinical laboratory testing is generally categorized as either of two general areas--clinical testing and anatomical pathology testing. Clinical and anatomical pathology procedures
|
2010 |
1.999,00$ |
| |
Regenerative Medicine Markets TriMark Publications TriMark Publications
Regenerative medicine is a way of treating injured and diseased human tissue by using laboratory-grown or therapeutically-induced human tissue as a replacement. As such, astounding
|
2010 |
3.400,00$ |
| |
Veterinary Health Markets TriMark Publications TriMark Publications
Profound changes are happening in the animal health market. Pet owners in the United States are demanding more advanced and expensive treatments for companion animals, driving grow
|
2010 |
3.400,00$ |
| |
Stem Cell Markets TriMark Publications TriMark Publications
A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological
|
2010 |
3.400,00$ |
| |
Women’s Health Diagnostic Testing TriMark Publications TriMark Publications
The purpose of this TriMark Publications report is to describe the specific segment of the in vitro diagnostics (IVDs) market called women’s health testing. This study includes con
|
2010 |
3.400,00$ |
| |
Patient Monitoring Markets TriMark Publications TriMark Publications
Patient monitoring is vital to care in operating rooms, emergency rooms, intensive care units and critical care units. It has proven invaluable for respiratory therapy, recovery ro
|
2009 |
3.400,00$ |
| |
Disposable Syringe Markets TriMark Publications TriMark Publications
This TriMark Publications report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor
|
2009 |
3.400,00$ |
| |
Global Beverages Report TriMark Publications TriMark Publications
Until recently, the beverages market was divided simply between alcoholic and non-alcoholic beverages. As consumers' tastes grew more sophisticated and demand surged for a variety
|
2009 |
3.400,00$ |
| |
Hematology Analyzer Instrumentation and Reagent Markets TriMark Publications TriMark Publications
Clinical hematology analyzer analysis is one of the oldest and most important sectors of clinical laboratory analysis. The hematology instrument and reagent market is centered arou
|
2009 |
3.400,00$ |
| |
Pharmacogenomics for Clinical Use and in Drug Development TriMark Publications TriMark Publications
Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying p
|
2009 |
3.400,00$ |
| |